A Practical Look at Direct-to-Patient Shipment
Join Calyx’s Sylvain Berthelot and learn what Direct-to-Patient (DtP) means and how it was applied during the pandemic. The presentation will highlight the risks of DtP and how the process benefits clinical trials and ways to be improved in the future.
Speakers
Sylvain Berthelot
Director, Solution Consultant, Calyx
Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.
